![]() Health policy experts and regulators have focused for decades on pharmaceutical companies’ payments to doctors-which research has shown can influence which drugs they prescribe. These payments come in various forms, from royalties for helping to design implants to speakers’ fees for promoting devices at medical meetings to stock holdings in exchange for consulting work, according to government data. Medical industry payments to orthopedists and neurosurgeons who operate on the spine have risen sharply, despite government accusations that some of these transactions may violate federal anti-kickback laws, drive up health care spending and put patients at risk of serious harm, a KHN investigation has found. Chin and SpineFrontier have yet to file a response in court. Chin had no comment on the civil suit, one of more than a dozen he has faced as a spine surgeon and businessman. In March 2020, the Department of Justice accused Chin and SpineFrontier of illegally funneling more than $8 million to nearly three dozen spine surgeons through “sham consulting fees” that paid them handsomely for doing little or no work. ![]() Yet SpineFrontier’s success arose not from the quality of its goods, these officials say, but because it paid kickbacks to surgeons who agreed to implant the highly profitable devices in hundreds of patients. Chin has patented more than 40 pieces of such hardware, including doughnut-shaped plastic cages, titanium screws, and other products used to repair spines-generating $100 million for his company SpineFrontier, according to government officials. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |